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ABSTRACT

Alyahya, Mashael Yahya A. M.S., Department of Pharmacology and Toxicology, Wright
State University, 2022. Replication Stress Induced by the Ribonucleotide Inhibitors
Guanazole, Triapine, and Gemcitabine in Fission Yeast.
Replication stress can be produced by various exogenous or endogenous factors that
perturb the movement of replication forks. To overcome the stress, eukaryotic cells
activate the DNA replication checkpoint to mobilize several pathways to protect the
forks, maintain genome integrity, and promote cell survival. Defects in the replication
checkpoint cause forks collapse, leading to chromosomal DNA damage or cell death.
Although the replication checkpoint is crucial for genome integrity in all eukaryotes, the
underlying mechanisms remains to be fully understood. To investigate the mechanisms of
the replication checkpoint, hydroxyurea (HU), an established inhibitor of ribonucleotide
reductase (RNR), has been widely used in laboratories as an inducer of the replication
stress. It depletes dNTP pools, slows down the movement of DNA polymerase at the
forks, and thus activates the replication checkpoint in yeasts and in mammalian cells.
Unfortunately, HU also targets other cellular components, which may complicate the
studies, leading to ambiguous description of the checkpoint mechanisms. The purpose of
this study is to find an RNR inhibitor that produces the replication stress more
specifically than HU in the fission yeast Schizosaccharomyces pombe. We examined
three RNR inhibitors, namely guanazole, triapine, and gemcitabine under several
experimental conditions that are commonly used in the laboratories for checkpoint
iii

studies. We found that among the three drugs, guanazole and triapine produce the
replication stress more specifically than HU under the chronic drug exposure conditions
such as spot assay. Under acute drug treatment conditions, however, guanazole and
triapine cause other cellular stresses more significantly than HU. Therefore, using
guanazole or triapine in chronic drug exposure conditions and HU in acute treatment can
produce replication stress specifically under various experimental conditions and thus
benefits the checkpoint studies in S. pombe and possibly the research in other model
systems.
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1. INTRODUCTION
1.1 Eukaryotic cell cycle and DNA Replication
A key characteristic for life is the ability of a cell to divide into two identical
daughter cells through a programmed mechanism known as cell cycle (1). Although
fission yeast and human cells are all eukaryotic, there are differences in their cell cycles.
One complete cell cycle of fission yeast takes about 3 hours. The growth phase 2 (G2) is
the longest phase where it consumes about 70% of the cell cycle time while growth phase
1 (G1), replication (S phase), and mitosis contribute to the remaining 30% in fission yeast
(2). Also, one important feature of Schizosaccharomyces pombe (S. pombe) is the
initiation of replication even before the cytokinesis finishes. Although DNA damage can
occur in any stage of the cell cycle, the cells are susceptible to the threats particularly
during DNA replication (3). During DNA replication, the double-stranded DNA helix
unwinds, employing each parent strand as a template to synthesize the nascent strand by
DNA polymerase (4). An accurate replication process can be interrupted by a variety of
endogenous and exogenous factors, which generates replication stress (3).
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1.2 DNA replication stress
Replication stress threatens the genome stability and cell viability. The stress is a
state where the fork movement is slowed or stalled. It usually does not indicate the
physical damages to the DNA structure such as double stranded breaks (DSBs) that
resulted from collapsed forks; however, it may generate a physical structure known as
extended stretches of single-stranded DNA (ssDNA) (5). The ssDNA usually arises
because the helicase proceeds to unwind the parent strands even in the presence of
slowed or halted DNA polymerase (6). In fact, the replication stress can be generated
under various circumstances, for instance, depletion or imbalance of the dNTP pools, the
precursors of DNA synthesis, lesions on the DNA templates, replication-transcription
conflicts, and lacking vital replication factors such as histones (5). Under these
conditions, the activated DNA replication checkpoint (DRC) deals with the stress by
stimulating dNTP production, preventing forks from collapse, and promoting cell
survival.
1.3 The DRC signaling pathway
The DRC is a cell cycle surveillance system evolved in eukaryotic cells to
preserve genome stability by protecting the stressed forks and arresting the cell cycle to
allow time for the DNA replication to be completed (7). Upon formation of ssDNA at the

2

slowed or stalled forks under stress, replication protein A (RPA) complex, composed of
RPA70, RPA32, and RPA14, binds to ssDNA to prevent its degradation (7,8). The
ssDNA-RPA complex works as a platform for recruiting Rad3 (ATR in mammals) and
Rad26 (ATRIP in mammals). In addition to Rad3 and Rad26, ssDNA-RPA promotes the
loading of a ring like sliding clamp called 9-1-1 complex composed of Rad9, Rad1, and
Hus1 onto the forks by the loader Rad17 and the replication factor C (RFC2-5) complex
(8).
Once the assembly of the checkpoint sensor proteins (Rad3, Rad26, Rad9, Rad1,
and Hus1) is completed at the fork, Rad3 is activated to phosphorylate the neighboring
Rad3 proteins in trans to intensify the signaling response, leading to full activation of the
DRC (7). In addition to the DRC, Rad3 also launches a signaling cascade of the DNA
damage checkpoint (DDC) pathway. When ssDNA generation occurs in S phase, the
DRC pathway is activated by Rad3-dependent phosphorylation of the mediator of
replication checkpoint Mrc1 and the effector kinase Cds1 (Claspin and Chk2 in
mammals, respectively) (9). When DNA damage occurs outside the S phase or in the case
of collapsed forks in DRC mutants, Rad3 phosphorylates Crb2 (53BP1 in mammals) and
Chk1 at the damage sites to initiate the DDC. The activated DRC suppresses the firing of
late replication origins, increases the production of dNTPs by upregulating the R2 subunit
of ribonucleotide reductase (RNR), safeguards and restarts replication forks, prevents
fork collapse and thus, prevents replication catastrophe and cell death (7,9,10). Defects in
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DRC are linked with mutagenesis and genetic diseases (4,11). Since the checkpoint
proteins are highly conserved from yeasts to humans throughout evolution (6), studying
the checkpoint using fission yeast as a model will provide further insights into the
checkpoint mechanisms.

Figure 1: The current model of the DRC and DDC signaling pathways
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When a replisome encounters a DNA lesion on the template, it leads to the slowing of
DNA polymerase movement, but not the unwinding helicase, generating ssDNA. The
resulting ssDNA binds RPA to form a complex which work as a platform to recruit the
sensors kinases Rad3 and Rad26 (ATR and ATRIP in human cells) (7). Another sensor
proteins complex termed as 9-1-1 (Rad9, Rad1, and Hus1) is assembled at the stalled
replication fork by the loader Rad17 and Rfc2-5 (8). When the checkpoint sensors are
assembled at the fork, Rad3 undergoes autophosphorylation and transmits the signal to
the mediator kinase Mrc1(Claspin in mammalian cells) (3). Then, Mrc1 mediates the
downstream signal transduction to the effector kinase Cds1 (Chk2 in humans) of the
DRC (9). If DNA damage occurs outside the S-phase of the cell cycle or in the presence
of collapsed forks which generate double strand breaks, Rad3 phosphorylates and
activates Crb2 (BRCA1 in mammals) and Chk1 of the DDC pathway (3).
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1.4 Activation of the DRC
Upon activation of the DRC, several mechanisms take place to overcome the
replication stress. These include increasing dNTPs levels, slowing the replication
progression, inhibiting the late firing origins, stabilizing the perturbed forks, and
preventing entry into mitosis. All these factors work in concert to maintain genome
stability and cellular proliferation. (12–15).
Although it is important for genome integrity, the DRC mechanism remains
incompletely understood. As illustrated earlier, DNA replication process could be
hindered by a variety of factors that generate replication stress. Some of the factors
include reactive oxygen species (ROS), ultraviolet light (UV), and methyl
methanesulfonate (MMS) that generate DNA damage (3,5). Although these DNA
damaging agents can activate the DRC, it also activates the DDC if the DNA damaging
effect occurs in G2 phase of the cell cycle, leading to a vague explanation of the DRC
mechanisms (16). Therefore, an agent that specifically produces replication stress is
critically important for the studies of the DRC.

1.5 Hydroxyurea
Hydroxyurea (HU) is a simple compound discovered in 1869 by Dresler and Stein
that was reported to have a potential antineoplastic activity in 1960’s (17). Since then, it
has been used for a wide range of conditions including sickle cell anemia, viral
infections, psoriasis, and several types of cancer (18,19). Taking advantages of its
6

cytotoxic effect, nowadays, it is used to treat skin cancer, chronic myeloproliferative
disorders, and many solid tumor types (18,20,21). The profound effect of HU was noted
in 1964 when it was found to inhibit RNR by quenching the tyrosine free radical, which
is required for the catalysis (22). It is the most widely used agent in laboratories to induce
the reversible replication stress and S phase cell synchronization. (22,23). Although it is
used to induce replication stress, HU may provoke DDC under different circumstances.
For example, if a DNA damage such as broken forks occur, when HU is used in high
doses or for long term exposure.

1.6 RNR, the primary target of HU.
The activated DRC inhibits cell division to allow time for DNA replication and
repair. Furthermore, it upregulates RNR to enhance dNTPs production. RNR is an
enzyme responsible for generating the four deoxynucleotide triphosphates (dNTPs), the
building blocks of DNA, by substituting the 2’-hydroxyl group of dNDPs with a
hydrogen atom (24,25). By regulating production of dNTPs, RNR tightly controls
mutational rate, therefore, enhances the DNA replication and repair (26). There are three
classes of RNR, I, II, and III. Among these, class I RNR is found in mammals, eukaryotes
and prokaryotes. RNR consists of two subunits in a dimeric form, the larger R1 (a)
subunit and the smaller R2 (b) subunit (Fig.2). Nucleotides are catalyzed in R1 subunit
where it contains the active reduction site. R1 also involves two allosteric sites, the first
7

site regulates the substrate specificity while the second site binds to ATP for enzymatic
activation or to dATP for inhibition. On the other hand, R2 which is highly expressed
during S-phase, harbors the diferric-oxygen center that yields the stable tyrosyl free
radical which travels to R1 via a long chain radical transfer pathway. Then it reduces
cysteine residues to produce thiyl radical which is responsible for RNR activity. HU
deactivates the tyrosyl radicals and thus inhibits RNR. This inhibition generates
replication stress and activates the DRC in yeasts and mammalian cells. (21,24,26–28).
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Figure 2: The Structure of Ribonucleotide Reductase
The enzyme consists of two subunits, R1 and R2. R1 regulates the dNTPs production and
R2 is essential for enzymatic activity through the presence of the tyrosyl free radicals
(29).

9

1.7 The secondary targets of HU
Extensive studies have been conducted to better understand the cell-killing
mechanisms of HU. As mentioned earlier, HU inhibits RNR, and thus, activates the DRC
(10,30). Mutants with a defective DRC are much more sensitive to HU than wild type
cells (10,14,31). However, previous studies revealed that some mutants that are sensitive
to HU possess an intact DRC (14,31). Since the DRC remains functional, the cytotoxic
effect of HU is unrelated to RNR inhibition. These mutants, namely hem13-1 and erg111, have defects in heme and ergosterol pathways, respectively. They manifest the cell
killing effect of HU by oxidative stress or cytokinesis arrest but not RNR inhibition
(14,31). These findings offer a deeper understanding of the cell killing effect of HU (32).
To see whether HU has other potential cellular target(s), further characterizations
of these mutants have taken place. Erg11 is a gene encoding sterol-14a-demethylase
essential for ergosterol biosynthesis and one study found that a single missense mutation
causing the G189D amino acid substitution in erg11 in S. pombe which sensitizes the cell
to HU (31). This mutation contributes to the lower ergosterol levels, and the cytokinesis
arrest induced by HU (31). It has also been reported that a T263I mutation in hem13, a
gene encoding coproporphyrinogen III oxidase required for heme biosynthesis, is
attributed to the HU teratogenic effect. The generation of ROS in the form of hydroxyl
radical is believed to be the underlying killing mechanism of HU in the hem13 mutant.
(14). However, both metabolic mutants have shown only a chronic (~3 days) but not an
10

acute sensitivity (~3 hours) to HU, which supports the notion that the cytotoxic effect of
HU is independent of RNR inhibition in these mutants.
This newly uncovered cell killing mechanisms of HU, although important for HUbased chemotherapies, may compromise the checkpoint studies. In this study, we tested
three RNR inhibitors namely guanazole, triapine, and gemcitabine, aiming to find an
agent that can produce replication stress more specifically than HU. Such an agent, once
identified, will be very helpful to the checkpoint studies, and that can lead to the
development of new chemotherapeutic regimens.
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1.8 RNR Inhibitors examined in this study

Figure 3: Chemical Structures of hydroxyurea, guanazole, triapine, and gemcitabine
1.8.1 Guanazole
Although guanazole (GZ) (Fig.3) was synthesized in 1893, its biological action
wasn’t reported until 1970 as antineoplastic for leukemia in mice (33). A phase I clinical
study on 27 patients with acute leukemia revealed a complete remission of two patients
and reported that myelosuppression is the main side effect (34). Thereafter, the interest in
GZ as a clinical agent for cancer treatment has been reduced since phase II trials were
never initiated. Another study reported that GZ and HU have the same DNA synthesis
and ribonucleotide effects in leukemia L1210 cells (33). Like HU, GZ inhibits the DNA
12

synthesis by suppressing RNR activity. However, it is less genotoxic and cost-effective,
which makes it superior to HU (33,35).
1.8.2 Triapine
Triapine (3-AP) belongs to the a-N-heterocyclic thiosemicarbazones class, and it
functions as a potent RNR inhibitor. It is 1000-fold more potent than HU in terms of
RNR inhibition. Currently, it is being tested in phase II clinical trials as a promising
antitumor compound (28,36). Shao J’s group suggested that 3-AP doesn’t have a direct
effect on the tyrosyl radical. Instead, it forms an active redox complex with iron to
generate ROS which destroy the tyrosyl radical (37). 3-AP has higher affinity to RNR
than HU, however, the action of both drugs is limited to the S phase of the cell cycle (38).
1.8.3 Gemcitabine
Gemcitabine (GEM) is a cytidine analogue. It was discovered as an antiviral, and
later as a cancer chemotherapeutic agent for the treatment of a wide range of tumors.
Currently, GEM is indicated as a first line treatment for pancreatic cancer, and in
combination with other anticancer drugs, it is also used in treating breast and non-small
cell lung cancer (39). GEM manifests a cell-cycle specificity in cells experiencing DNA
synthesis (40). It is transported into cells by a transporting system consisting of five
nucleoside transporters (41). It is a prodrug that it is converted intrinsically into the active
di- and triphosphate nucleosides by deoxycytidine kinases (40). The two metabolites
inhibit the synthesis of DNA by dual cytotoxic mechanisms. The diphosphate derivative
13

inhibits RNR, thus, decrease the dNTP levels including dCTP. While the triphosphate
nucleoside competes with dCTP for DNA incorporation (40). As a result, the low level of
the intracellular dCTP promotes integration of gemcitabine diphosphate into DNA and
thus, further inhibiting DNA synthesis (42,43). Earlier studies suggest that GEM causes a
complete S phase arrest, which leads to a maximum checkpoint activation (44).

1.9 S. pombe, the model organism
The fission yeast S. pombe is used as the model system in this study. It is a
unicellular, rod-shaped eukaryotic cell which was first isolated from millet beer in east
Africa (45). The pure culture of S. pombe was made by Lindner and colleagues in the
1890s (45). Lindner called it Schizosaccharomyce because it replicates by fission, and
pombe is the Swahili word for beer. It consists of three fully sequenced chromosomes
with a majority of the genes being conserved in higher eukaryotes (45,46). S. pombe
grows easily and exponentially in every three hours. So far, all checkpoint proteins have
known homologues in S. pombe, which makes it an ideal model to study the checkpoint
mechanism. We hypothesized that some of the tested RNR inhibitors would cause
replication stress and activate the DRC more specifically than HU in S. pombe.
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2. SPECIFIC AIMS
1. To examine the chronic and acute cell-killing effects of GZ, 3-AP, and GEM.
2. To assess the replication checkpoint activation by detecting the phosphorylation of
Mrc1.
3. To analyze the cell cycle progression.
4. To study cellular morphology via microscopic analysis.

15

3. MATERIALS AND METHODS
3.1 Yeast Strains and Chemicals
Standard methods and genetic techniques were used for the yeast cell culture (47). Yeast
strains used in this study are listed in Table. 1. The media used for cell culture was YE6S
(0.5% yeast extract, 3% glucose, and the six essential supplements, adenine, uracil,
histidine, lysine, leucine and arginine). Stock solution of 1.0 M GZ (AlfaAesar, Ward
Hill, MI or Sigma-Aldrich, St.Louis, MO) was prepared by dissolving 9.91g in 100 mL
of YE6S medium. GEM (AmBeed, Arligton Hts, IL) was prepared by dissolving in YE6S
medium. 3-AP (ApexBio Tech LLC, Boston, MA) was dissolved in DMSO. HU (SigmaAldrich, St.Louis, MO) was dissolved in sterile deionized water.

3.2 Drug sensitivity
The sensitivities were tested by spot assay, acute spot assay, and colony recovery assay.
For the spot assay or chronic drug exposure, the logarithmically growing S. pombe
culture was collected in 1 OD/ml (or 2x107 cells/ml), diluted in fivefold steps, and
spotted on YE6S plates containing HU, GZ, GEM or 3-AP at the indicated concentration.
The YE6S plates without the drugs were used as control. As the control plates for 3-AP,
equal amount of DMSO was added. The plates were incubated at 30°C for 3 days and
then scanned.
For examining the acute drug sensitivity, spot assay and the colony recovery assay were
performed. For the acute spot assay, HU, GZ, or 3-AP were added to logarithmically
16

growing cultures. 0.5 OD of cells was removed every two hours, washed once with
deionized water, diluted ten times in water, and spotted on YE6S plates. The plates were
incubated at 30°C for 3 days and photographed. In the colony recovery assay (48), a
sample of the culture was collected every hour during the drug treatment, diluted 1000fold in deionized water, spread onto YE6S plates, and incubated at 30°C for the cells to
recover for 3 days. The colonies were counted and plotted as percentages of the survival
rate. Each data point represents the log of the average cell survival percent calculated
from three separate plates. Error bars represent standard deviations of triplicates.

3.3 Western Blotting
Phospho-specific antibody against phosphorylated Mrc1-Thr645 was generated using the
chemically synthesized phosphopeptides described in our previous studies (9,49). The
fission yeast cells were fixed in 15% trichloroacetic acid (TCA) on ice overnight and
lysed by a mini-bead beater. The lysate was separated on an 8% gel by SDS-PAGE and
transferred to nitrocellulose membrane for western blot examination. The membrane was
stained with Ponceau S and was used as a loading control. After extensive washing with
distilled water, the blot was blocked with 5% milk and probed with the phospho-specific
antibody in 5% milk solution for 3 hours to detect the phosphorylated Mrc1. The blot was
then treated with secondary antibody. The same blot was stripped by incubating it at
70°C in a buffer composed of 50mM Tris:HCl (pH 7.5), 50mM DTT, and 2% SDS,
washed extensively with distilled water, and reprobed with polyclonal antibody against
17

Mrc1 to show the protein levels. Using ChemiDoc XRS imaging system (Bio-Rad), the
blotting signals were detected by electrochemiluminescence. The band intensities were
quantified using ImageLab (Bio-Rad).

3.4 Flow cytometry
0.5 OD cells were collected by centrifugation and fixed overnight in 70% ice-cold
ethanol at 4°C. The fixed cells were treated with 50 mM sodium citrate containing 0.1
mg/ml RNase A at 37°C for ³ 3hr. The cells were stained with 4 µg/ml propidium iodide
(PI), extensively vortexed and analyzed by Accuri C6 flow cytometer using FL2-A
channel. FCS Express 4Flow software was used to analyze the data.

3.5 Microscopy
S. pombe cells were incubated with either 15 mM HU or 200 mM GZ for 3 hours at
30°C. 0.5 OD cells were centrifuged, washed once with PBS, and centrifuged again.
About 2 µl of cells was removed directly from the pellet, placed onto a glass slide, and
heat-fixed briefly at 70°C. The fixed cells were stained with Blankophor (1:50 dilution in
PBS) and Hoechst (1:50 dilution in PBS). The cells were visually examined using an
Olympus EX41 fluorescent microscope. Images were captured with an IQCAM camera
(Fast1394) using Qcapture Pro 6.0 software and exported to Adobe Photoshop to create
the figure.
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Table 1: List of S. pombe strains used in the study

Strain

Genotype

Source

TK48

h- leu1-32 ade6-M216

Kelly lab

NR1826

h- ∆rad3::ura4 leu1-32 ura4-D18 ade6

Russell lab

TK197

h+ ∆chk1:ura4 leu1-32 ura4-D18 ade6-M210

Kelly lab

YJ15

h+ mrc1:ura4 leu1-32 ura4-D18 ade6-M210

Lab stock

GBY191

h+ ∆cds1:ura4 leu1-32 ura4-D18 ade6

Lab stock

Erg11-1

h+erg11(G189D): ura4+ leu1-32 ura4-D18 ade6-M210

Lab stock

APS19

h+ hem13(T263I)-1 cds1-6his2HA(Int) leu1-32 ura4-D18 ade6-M210

Lab stock
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4. RESULTS
4.1 Sensitivity of S. pombe to GZ, GEM, and 3-AP determined by spot assay.
The cytotoxic effect of GZ, GEM, and 3-AP was determined by the spot assay.
Spot assay is simple, fast and has been widely used in genetic screening. In this
experiment, HU was included for comparison. To assess the replication stress induced by
the RNR inhibitors, the following S. pombe strains were used: wild type (TK48), the
checkpoint mutant cells rad3∆ (NR1826), mrc1∆ (YJ15), chk1∆ (TK197), and cds1∆
(GBY191), and two metabolic mutants erg11-1 (YJ1296) and hem13-1 (APS19) (14,31)
(Table1). The wild type S. pombe cells were used as a control, whereas rad3∆, mrc1∆,
chk1∆, and cds1∆ mutants were used to examine the checkpoint response to the induced
replication stress. Because erg11-1 and hem13-1 are sensitive to HU due to other stresses
such as cytokinesis arrest and oxidative stress (14,31), they are used as indicators for
other potential stresses. As mentioned previously, Rad3ATR is the sensor kinase for both
the DRC and the DDC. S. pombe lacking Rad3 is highly sensitive to the replication stress
and the DNA damage due to a lack of the DRC and the DDC. However, mutants of the
Rad3-Mrc1-Cds1 (DRC pathway), but not Rad3-Crb2-Chk1 (DDC pathway), are highly
sensitive to the replication stress.
As shown in Fig. 4, top panel, rad3∆, mrc1∆, and cds1∆ cells showed a
sensitivity to HU, whereas chk1∆ mutant is less sensitive, indicating that the replication
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stress induced by HU is mainly dealt with by the DRC, and not the DDC. However,
chk1∆ cells showed sensitivity when HU was increased to 5 mM, suggesting that even in
the presence of functional DRC, the DDC was also activated likely by the DNA damage
resulting from the collapsed forks. Consequently, mrc1∆ and cds1∆ showed a sensitivity
to HU while rad3∆ cells were more sensitive than mrc1∆ and cds1∆ which is consistent
with the function of Rad3 in both DRC and DDC. Although erg11-1 and hem13-1 show a
similar or even higher sensitivity than rad3∆ mutant in the spot assay (Fig. 4 lower
section of the top panel), they are not sensitive to HU under the acute treatment in liquid
culture for 8 hours, suggesting that in addition to the replication stress, HU causes other
stresses leading to cell death of the metabolic mutants in the chronic spot assay (14,31).
To find an agent that activates DRC more specifically, three RNR inhibitors GZ, GEM,
and 3-AP were tested under similar conditions. As shown in Fig. 4 lower right panel,
GEM doesn’t have any growth inhibitory effect to all tested strains when up to 77.5 mM
was used (results with lower concentrations are not shown). GZ and 3-AP caused a
higher cytotoxic effect on rad3∆ and cds1∆ than chk1∆ and wild type S. pombe,
suggesting that they produce replication stress. Furthermore, the chk1∆ mutant treated
with 60 mM GZ is less sensitive than 5 mM HU, which suggests that the replication
stress induced by GZ is mainly dealt with by the DRC. Notably, the two metabolic
mutant strains were less sensitive to 15 mM GZ and 0.25 mM 3-AP than 1.25 mM HU
under similar conditions. However, when the concentrations of GZ and 3-AP were
increased, the metabolic mutants were also sensitive, which suggests the presence of
21

other cellular stress in addition to replication stress when higher doses were used (see
below). Therefore, GZ and 3-AP can more specifically produce replication stress than
HU in the spot assay. Between the two drugs, GZ is more cost-effective (about 30% less
than HU), we recommend using GZ to generate the replication stress under chronic drug
exposure conditions such as the spot assay. To exclude the possibility that the cell killing
effect of GZ is due to the presence of impurities, GZ samples from two different
manufacturers were compared side by side. Yet, the results were very similar, if not
identical, suggesting that the observed cytotoxic effect is caused by GZ, and not the
impurities associated with the samples.
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Figure 4: Chronic drug sensitivity of wild-type (WT), rad3∆, chk1∆, mrc1∆, cds1∆,
erg11-1, and hem13-1 analyzed by spot assay
Fivefold dilution series of the logarithmically growing S. pombe were prepared and
spotted on YE6S plates containing HU, GZ, GEM or 3-AP at the indicated
concentrations. While the control plates contained only YE6S medium, the drug plates
contained HU, GZ, and GEM. 0.5% of DMSO vehicle control was included in the non-
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drug plates for 3-AP. The plates were then incubated in 30°C for 3 days and then
photographed.
4.2 Acute cell-killing effect of GZ and 3-AP.
Based on the results by spot assay, we selected GZ and 3-AP to further investigate
their inhibitory cell growth effects in liquid cultures. GEM was excluded from
subsequent analysis because it does not show any growth inhibitory effect in S. pombe.
To study the acute drug sensitivity in liquid medium, two methods were used: acute spot
assay and colony recovery assay.
In the acute spot assay, GZ and 3-AP were added to liquid YE6S cultures of wild
type and rad3∆ cells at the indicated concentrations. For comparion, 15 mM HU was
included in this experiment. While the cultures were incubated at 30 °C in the presence of
the drugs, a small number of cells was removed every two hours during the drug
treatment, washed once with deionized water, diluted ten times, and spotted on YE6S
plates. To allow cell recovery, the plates were incubated at 30 °C for 3 days. As shown in
Fig. 5A, HU showed the cytotoxic effect to rad3∆ but not the wild type cells after 2 hours
of incubation. Under similar conditions, 3-AP did not show any cell-killing effect during
the 8 hours of treatment in the presence of 5 mM or 7 mM concentration. This may be
because 3-AP is transported into the cells very slowly, which prevents its cytotoxic effect
during the acute treatment. However, GZ showed a toxicity to rad3∆ cells at
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concentrations ranging from 50 mM to 250 mM (Fig. 5B). Based on these results, we
conclude that unlike 3-AP, GZ is capable of inducing replication stress under the acute
treatment conditions. Surprisingly, despite the concentrations of GZ were increased, the
growth inhibition of rad3∆ did not increase accordingly and never reached the level of 15
mM HU. This result is consistent with the data in Fig. 4, suggesting that GZ may also
generate another type of stress causing G2/M delay, which indirectly suppresses to some
extent the cytotoxic effect caused by the replication stress in liquid cultures.
To further analyze the replication stress induced by GZ, we performed the colony
recovery assay. In this assay, a 15 mM HU or 200 mM GZ was added to the liquid
culture containing wild type, rad3∆, cds1∆, and erg11-1 cells and incubated at 30 °C.
Every hour during the treatment, a small amount of the culture was removed, diluted
1000 times, and spread onto three YE6S plates to recover. The plates were incubated at
30 °C for 3 days. The recovered colonies were counted and shown in percentages of the
cell survival rate. As shown in Fig. 5C, both wild type and erg11-1 cells exhibited a
similar resistance to HU and GZ. Although erg11-1 was sensitive to HU under chronic
conditions (Fig. 4), it is resistant to the acute treatment, which confirms our previously
published results (14,31). The cds1∆ mutated cells were less sensitive than rad3∆ in HU,
which is consistent with the results shown in Fig. 4 and with the roles of Cds1 and Rad3
in the checkpoint pathways. As shown in Fig. 5C right panel, cds1∆ and rad3∆ were
more sensitive than erg11-1, which indicates the presence of replication stress. In contrast
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to HU, GZ sensitizes rad3∆ and cds1∆ cells in a similar pattern. Together, in addition to
Fig. 4, these results show that on top of the replication stress, GZ may cause another
stress during the acute treatment that suppress the cytotoxic effect in the rad3∆ cells.

Figure 5: Acute drug sensitivity of wild type and rad3∆ cells analyzed by acute spot and
colony recovery assays
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(A) WT and rad3∆ cells were treated with 15 mM HU (green line), or 5 mM and 7 mM
3-AP (red lines). A small amount of the culture was removed every two hours during the
treatment, washed once and spotted on YE6S plates. The plates were incubated at 30 ̊C
and then photographed. (B) WT and rad3∆ mutant cells were treated with 15 mM HU
(green line) or increasing concentrations of GZ (red lines). Dash line indicates
discontinuity. (C) The sensitivity of WT, erg11-1, rad3∆, and cds1∆ cells to HU and GZ
was determined by cell recovery assay. The cells were treated with 15 mM HU (left
panel) and 200 mM GZ (right panel) in YE6S liquid medium. The cells were spread onto
YE6S plates every hour during the drug treatment and incubated at 30°C for three days to
recover. The colonies were counted and plotted as percentage against time. Error bars
represent standard deviations of triplicates.

4.3 Effect of GZ on Rad3 kinase signaling in the DRC.
Next, we examined the phospho-signaling of DRC to confirm the presence of
replication stress induced by GZ. Considering that 3-AP did not show any acute cytotoxic
effect, it was not further studied. In the presence of replication stress, Rad3
phosphorylates two Mrc1 residues, Thr645 and Thr653 that can be monitored by western
blotting using the phospho-specific antibody as explained in our previous studies
(9,10,49). The phosphorylated Mrc1 facilitates signals transmission from Rad3 to Thr11
residue in Cds1, which encourages the autophosphorylation of Thr328 and the
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autoactivation of Cds1, the effector kinase of the DRC (9). Hence, Mrc1 is a molecular
indicator of the activated DRC and of the presence of replication stress.
In Fig. 6A, Mrc1-Thr645 phosphorylation was examined in wild type cells treated
with increasing concentrations of GZ. When the concentration of GZ increased, the levels
of Mrc1 phosphorylation were also increased accordingly until it reaches a plateau (Fig.
6B, blue line). Consistent with the results shown in Fig 4 and 5, 200-300 mM of GZ
stimulates Mrc1 phosphorylation at levels comparable to that in cells treated with 15 mM
HU. Mrc1 is expressed specifically in S-phase (9) and the activated DRC promotes the
expression of Mrc1 (50). Therefore, the Mrc1 protein level is much higher in GZ-treated
cells than in untreated cells (Fig. 6B, orange line). Interestingly, Mrc1 phosphorylation
decreased when the concentrations of GZ were higher than 150 mM. These data together
with that shown in Fig 4 and 5 suggest the presence of another type of stress apart from
the replication stress, causing G2/M arrest (see below). The G2/M arrest has been shown
in erg11-1 and hem13-1 cells when a higher dose of HU was used, which indirectly
affects the levels of Mrc1 protein and its phosphorylation (21,31).
To investigate if the Mrc1 phosphorylation is dependent on Rad3 in GZ-treated
cells and if the phosphorylation occurs in erg11-1 cells, western blot analysis was
performed in cells treated with 15 mM HU or 200 mM GZ. As shown in Fig. 6C, Mrc1
phosphorylation levels in GZ-treated cells were higher than the control but lower than
HU-treated cells. Notably, in rad3∆ and mrc1∆ cells treated with either HU or GZ, the
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Mrc1 phosphorylation was eliminated. This is consistent with the signaling cascade of the
DRC pathway which is controlled by the master checkpoint kinase Rad3. In other words,
the phosphorylation of Mrc1 in the presence of GZ is also dependent on Rad3, which
supports the acute induction of replication stress by GZ in vivo. As explained earlier,
erg11-1 mutant showed a G2/M cell cycle arrest in HU. Thus, upon the treatment of
erg11-1 with HU, Mrc1 phosphorylation levels was lower than in wild type cells.
Likewise, Mrc1 phosphorylation levels in GZ-treated erg11-1 cells were also lower than
in wild type cells. Overall, these results strongly imply that higher doses of GZ induce
another stress, causing a G2/M cell cycle arrest (see below).

Figure 6: HU or GZ-induced Rad3-dependent Mrc1 phosphorylation
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(A) Mrc1 phosphorylation in the presence of GZ or HU. Wild-type cells were treated
with 15 mM HU or increasing concentrations of GZ for 3 hours. An equal number of
cells were fixed in 15% TCA and lysed by mini-bead beater method. The whole cell
lysate was separated on 8% SDS PAGE for Western blot analysis using the phosphospecific antibody (top panel). In the middle panel, the same blot was stripped and
reprobed with anti-Mrc1 antibodies for Mrc1 protein level detection. A section of
Ponceau S stained membrane was shown as the loading control (bottom panel). (B) The
bands from the blot shown in A were quantified and represented as percentages of
relative levels of protein (orange line) and phosphorylation (blue line) of Mrc1. (C) The
WT and the indicated S. pombe mutant cells were treated with 15 mM of HU or 200 mM
of GZ for 3 hours and analyzed as in (A).

4.4 Effect of GZ on cell cycle progression.
The results described above suggest that in addition to replication stress, GZ may
also induce another stress, which perturbs the cell-cycle progression. To investigate this
possibility, cell-cycle analysis was carried out in the presence of 200 mM GZ. Two sets
of controls, wild type and rad3∆ treated with 15 mM HU were included in this
experiment. At every hour time point of the drug treatment, 0.5 OD cells were removed
and fixed for flow cytometry analysis. The results showed that the majority of the cells
show a 2C content at 0 hour (Fig. 7, red line) because the S phase is very brief, and the
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DNA replication starts before the completion of mitosis. It is also shown that both the
wild type and rad3∆ cells were arrested by HU at the S-phase during the first 3 hours of
incubation (Fig. 7, green line). However, when treated with GZ, the cells were arrested in
G2/M phase during the 6 hours of treatment (Fig. 7 red line). This G2/M arrest aligns
with the molecular evidence shown in Fig. 6B that while GZ causes replication stress, the
majority of S. pombe cells were arrested at the G2/M phase, not at S-phase, suggesting
the presence of another type of stress that arrests the cells at G2/M particularly when
higher concentrations of GZ were used. This side effect of GZ, which may function
similarly as the DNA damage checkpoint, explains the reduced sensitivity of rad3∆
mutant to GZ in Fig. 5 as well as the reduced expression in the protein and
phosphorylation levels of Mrc1 in wild type cells shown in Fig. 6.
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Figure 7: Cell cycle analysis of wild type and rad3∆ cells treated with HU or GZ
examined by flow cytometry
HU or GZ was added to wild type or rad3∆ cultures at the indicated concentrations.
Every hour during the incubation, an equal number of cells was collected and fixed with
75% ethanol. The fixed cells were then treated with RNase and propidium iodide for flow
cytometry analysis. The green and red lines represent 1C and 2C DNA content,
respectively.
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4.5 Microscopic examination of cells treated with GZ
Replication stress is dealt with by the DRC. As mentioned above, the activated
DRC mobilizes several cellular functions to ensure genome integrity and the viability of
the cells. One of the cellar functions involves suppressing mitosis so that the cells have
enough time to complete the DNA replication before cell division. However, S. pombe
cells with a defective DRC such as rad3∆ mutant proceed into premature or aberrant
mitosis in the presence of replication stress. This phenotype is called “cell untimely torn”
or cut (51) and it is likely the direct cause for cell death in HU. Therefore, the cut
phenotype is a strong indicator of the DRC defect in the presence of HU-induced
replication stress. However, acute HU treatment causes cytokinesis arrest in erg11-1
cells, not the cut cells, suggesting the side effect of HU in this mutant (31). To further
investigate the replication stress and the side effect of GZ, we examined the cut
phenotype and cell morphology under microscope in GZ treated S. pombe. For this
purpose, we treated wild type, rad3∆, mrc1∆, and erg11-1 cells with 200 mM GZ or 15
mM HU for 3 hours. The cells were fixed by brief heating, stained with Hoechst for
genomic DNA and Blankophor for septum, and examined under microscope.
As shown in Fig. 8, most of wild type cells treated with HU were elongated with
one nucleus in the center, which indicates the activation of DRC. In contrast, most of the
HU-treated rad3∆ cells showed the cut phenotype (Fig. 8, red arrows) where the cells
were short, formed the septum that separate daughter cells with either undetectable or
33

different amounts of genomic DNA. The HU-treated mrc1∆ cells also elongated but
lacked the cut phenotype, which is consistent with the functional DDC. The HU-treated
erg11-1 cells clearly showed the septum (Fig. 8, green arrows) and one nucleus in each of
the unseparated daughter cells, consistent with the cytokinesis arrest. In the presence of
GZ, however, all S. pombe cells did not elongate. Furthermore, rad3∆ mutant did not
show the cut phenotype even though the Mrc1 phosphorylation levels were significantly
increased. This result suggests that the G2/M arrest caused by GZ prevents rad3∆ cells
from undergoing a mitotic catastrophe, which provides an additional support to the notion
that GZ causes G2/M arrest although the replication stress was generated under the same
conditions. Since rad3∆ mutants did not show any cut phenotype and erg11-1 cells did
not show a cytokinesis arrest, it is possible that GZ stalls the cell cycle at late G2 or M
phase.
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Figure 8: Microscopic examination of wild type, rad3∆, mrc1∆, and erg11-1 cells
treated with HU or GZ
The cells were treated with 15 mM HU or 200 mM GZ for 3 hours and fixed by brief
heating. After staining with Hoechst and Blankophor, they were examined under
microscope. The red arrows indicate the cut cells in rad3∆ induced by HU. The green
arrows indicate the cytokinesis arrest in HU-treated erg11-1 cells.
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5. DISSCUSSION
Replication stress is unavoidable in all proliferating cells that leads to DRC activation
to prevent DNA damage, mutagenesis, and thus, prevents the formation cancerous cells
(52). Although it has been extensively investigated, the mechanism of the DRC is still
incompletely understood and need further studies. Hydroxyurea is the commonly used
drug in the laboratories to generate replication stress for checkpoint studies. However, it
has undesirable side effects that compromise its usage in the checkpoint research. In this
study, we tested three other RNR inhibitors GZ, 3-AP, and GEM in S. pombe aiming to
find a drug that is better than HU in specifically inducing the replication stress. Among
these tested agents, GEM did not show any cell growth inhibitory effect in the spot assay
at a concentration as high as 77.5 mM. One explanation is that it cannot be transported
into the cell due to its bulky structure as compared with HU (Fig. 3). Alternatively, unlike
mammalian cells, S. pombe lacks the transporter for its influx. In mammalian cells, GEM
not only requires a transporting system composed of five nucleoside transporters to enter
the cell, but it also requires a nucleoside kinase to be converted into its active metabolites
(41,42). S. pombe may lack the kinase and the transporters, leading to the insensitivity. It
has been reported that expressing the exogenous human equilibrate nucleoside transporter
and thymidine kinase from herpes virus increased the incorporation of thymidine analogs
into the DNA of fission yeasts (53). It remains to be seen whether GEM is cytotoxic in
the S. pombe expressing the exogenous transporter and the thymidine kinase. Like GEM,
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3-AP is a large and bulky drug. Although it did not cause acute cytotoxicity, it showed a
chronic lethal effect in S. pombe. The cytotoxicity of 3-AP is thought to be due to
replication stress (Fig. 4) because rad3∆ and cds1∆ cells were significantly more
sensitive than the wild type cells. Surprisingly, the fission yeast was insensitive to 3-AP
under acute conditions. It is likely due to its bulky structure or its hydrophilicity that
hinders it from penetrating the cell wall of S. pombe in a short time. Therefore, 3-AP may
enter the cell slowly (3 days for chronic vs 8 hours for the acute drug treatment) and
show the growth inhibitory effect only in the spot assay.
Among the three tested RNR inhibitors, GZ is the only drug that exhibits both
chronic and acute sensitivity in S. pombe. In the chronic spot assay, rad3∆ and cds1∆
mutants are much more sensitive than wild type cells, which indicates the presence of
replication stress. Furthermore, GZ is more specific than HU in producing replication
stress under chronic conditions since it causes less sensitivity in the metabolic mutants.
The mrc1∆ mutant was slightly less sensitive to GZ and HU than cds1∆ probably due to
the basal Rad3-dependent phosphorylation of Cds1 (10). While GZ induces replication
stress under acute conditions, it arrests majority of wild type and rad3∆ cells in G2/M,
not S phase, which strongly suggests a side effect of GZ. This side effect may arise due to
the fact that high concentrations of GZ are required to induce replication stress and to
activate the checkpoint efficiently. The G2/M cell cycle arrest may function similarly to
the activated DDC, which suppress the cytotoxicity caused by the GZ-induced replication
stress. Indeed, HU also halts the cell cycle at G2/M in wild type S.pombe when 50 mM is
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administrated (31). The G2/M arrest induced by higher concentrations of GZ would also
explain the reduced cytotoxicity in rad3∆ cells (Fig. 4), and the absence of the cut
phenotype in GZ-treated S. pombe (Fig. 8). Together, our results show that GZ and 3-AP
can replace HU to produce replication stress more specifically in S.pombe only under the
chronic conditions such as the spot assay, a method commonly used for genetic studies in
yeasts. Between GZ and 3-AP, GZ is a better choice for this assay because of its lower
cost. Nevertheless, none of the three RNR inhibitors was able to replace HU for
generating acute replication stress in fission yeast. Therefore, using GZ for producing the
replication stress under chronic conditions and HU for inducing acute replication stress
would complement each other and benefit the checkpoint research. Because of the
conserved nature of the DRC throughout the evolution, these results will likely assist the
checkpoint research in other model systems.
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6. CONCLUSION
DNA is continuously threatened by exogenous or endogenous damaging agents that
cause mutations and increase the cancerous risk. However, the cells adapt various control
mechanisms that deal with the generated stress to maintain genome integrity and cellular
viability. One of these mechanisms is the DNA replication checkpoint which maintains
the genome integrity under replication stress. Although it has been investigated for the
past decades, the mechanisms of the replication checkpoint remain not fully understood.
Hydroxyurea is the commonly used drug in the laboratories to generate replication stress
for checkpoint study. Yet, the checkpoint research is sometimes compromised due to the
unwanted side effects caused by HU. In this study, we tested three RNR inhibitors GZ, 3AP, and GEM in S. pombe under various experimental conditions in order to find a drug
that can produce replication stress more specifically than hydroxyurea. Our data show
that among these three drugs, GZ produces replication stress more specifically than
hydroxyurea only under chronic conditions. When high concentrations of GZ is used to
produce acute replication stress, it arrests the cell cycle at G2/M, not at S phase,
indicating a side effect which may indirectly suppress the activation of the replication
checkpoint. Together, we propose that employing GZ under chronic conditions and HU
in acute experiments can avoid the side effects of both drugs and produce the replication
stress more specifically under various experimental conditions. This result will benefit
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the checkpoint research in S. pombe and likely the related studies in other experimental
model systems.
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